FDA Inspection 1262171 — Amnii-X LLC
The FDA completed an inspection of Amnii-X LLC on February 18, 2025 in Plano, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 18, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Plano, TX (United States)